These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22560411)

  • 21. Managing diabetic retinopathy.
    Ockrim Z; Yorston D
    BMJ; 2010 Oct; 341():c5400. PubMed ID: 20974661
    [No Abstract]   [Full Text] [Related]  

  • 22. Tele-ophthalmology for diabetic retinopathy in Canada-meeting the needs of a growing epidemic.
    Kanjee R; Dookeran RI
    Can J Ophthalmol; 2016 Jun; 51(3):133-4. PubMed ID: 27316256
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ocular complications in diabetes: towards standardizing screening and care].
    Massin P
    Rev Prat; 2001 Oct; 51(16):1776-82. PubMed ID: 11795121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Better outcomes for patients with diabetic macular edema.
    Schachat AP
    Ophthalmology; 2011 Apr; 118(4):607-8. PubMed ID: 21459213
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving Outcomes for Patients With Diabetic Macular Edema.
    Puliafito CA; Dugel PU; Cousins SW; Packo KH; Eaton AM; Parrish RK; Kiss S; Reichel E
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):S5-S15. PubMed ID: 26653894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Visual prognosis of laser treatment for diabetic retinopathy].
    Liu Y; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):247-51. PubMed ID: 19349681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rethinking Management Strategies for Proliferative Diabetic Retinopathy.
    Tang PH; Hariprasad SM; Do DV
    Ophthalmic Surg Lasers Imaging Retina; 2018 Apr; 49(4):224-227. PubMed ID: 29664976
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetic retinopathy.
    Barr CC
    J Ky Med Assoc; 1986 Apr; 84(4):155-8. PubMed ID: 2422308
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).
    Jorge R; Costa RA; Calucci D; Cintra LP; Scott IU
    Retina; 2006; 26(9):1006-13. PubMed ID: 17151487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment.
    Schweitzer KD; Eneh A; Gale J
    Can J Ophthalmol; 2011 Jun; 46(3):227-31. PubMed ID: 21784206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
    Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG
    Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal aflibercept for diabetic macular edema.
    Korobelnik JF; Do DV; Schmidt-Erfurth U; Boyer DS; Holz FG; Heier JS; Midena E; Kaiser PK; Terasaki H; Marcus DM; Nguyen QD; Jaffe GJ; Slakter JS; Simader C; Soo Y; Schmelter T; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Zeitz O; Metzig C; Brown DM
    Ophthalmology; 2014 Nov; 121(11):2247-54. PubMed ID: 25012934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)].
    ; Ziemssen F; Helbig H; Lemmen KD; Spital G; Bertram B; Hillenkamp J; Bartz-Schmidt KU; Bornfeld N; Bresgen M; Eter N; Friedrichs W; Heimann H; Hoerauf H; Holz FG; Kampik A; Kirchhof B; Pauleikhoff D; Roider J; ; ;
    Klin Monbl Augenheilkd; 2013 Jun; 230(6):614-28. PubMed ID: 23794430
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of Diabetic Macular Edema: Is It Time to Say Goodbye to Macular Laser?
    Chen X; Modjtahedi BS; Young LH
    Int Ophthalmol Clin; 2015; 55(4):113-22. PubMed ID: 26322431
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prevention and Treatment of Retinal Complications in Diabetes.
    Schorr SG; Hammes HP; Müller UA; Abholz HH; Landgraf R; Bertram B
    Dtsch Arztebl Int; 2016 Dec; 113(48):816-823. PubMed ID: 28073426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.
    Chen E; Park CH
    Retina; 2006; 26(6):699-700. PubMed ID: 16829817
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography.
    Pemp B; Deák G; Prager S; Mitsch C; Lammer J; Schmidinger G; Scholda C; Schmidt-Erfurth U; Bolz M;
    Retina; 2014 Dec; 34(12):2407-15. PubMed ID: 25062440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of diabetic retinopathy and diabetic maculopathy in elderly patients with diabetes mellitus].
    Nishitsuka K; Yamashita H
    Nihon Rinsho; 2013 Nov; 71(11):2005-9. PubMed ID: 24397174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management paradigms for diabetic macular edema.
    Mitchell P; Wong TY;
    Am J Ophthalmol; 2014 Mar; 157(3):505-13.e1-8. PubMed ID: 24269850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.